[Elsevier] Is neoadjuvant immunotherapy necessary in patients with programmed death ligand 1 expression-negative resectable non-small cell lung cancer? A systematic review and meta-analysis

NaveenMummudi Post time 2024-4-24 17:50:33 | Show all posts |Read mode
Reward20points

journal:Lung Cancer

Authors:Shu-Ling Zhang; Yuan Tian; Jing Yu; Jie-Hui Zhang; Li Sun; Le-Tian Huang; Jie-Tao Ma; Cheng-Bo Han

Published date:2024-4-

DOI:10.1016/j.lungcan.2024.107799

PDF link:https://www.sciencedirect.com/sc ... 169500224003313/pdf

Article link:http://dx.doi.org/10.1016/j.lungcan.2024.107799

Article Source:Elsevier BV


Remark:

Best Answer

Reply

Use magic Donate Report

All Reply1 Show all posts
aninagonzalez Post time 2024-4-24 17:50:34 | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report


Junior Member
  • post

  • reply

  • points

    90

Latest Reply



Return to the list